The new value of Nigeria's GDP adds previously uncounted industries like telecommunications, information technology, music, airlines, burgeoning online retail outlets and Nollywood film production that didn't exist when the last GDP count was made in 1990. Then, there were 300,000 landlines. Today, Nigeria has 100 million cell phone users.
The new figures also will take account of growth in agriculture and tourism that have flourished since democracy was restored in 1999, ending decades of military dictatorship.
Best Information Technology Companies To Invest In 2015: AVEO Pharmaceuticals Inc.(AVEO)
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of cancer therapeutics. The company?s lead product candidate, Tivozanib (AV-951), is a novel, highly potent and selective oral inhibitor of the vascular endothelial growth factor, or VEGF, receptors 1, 2, and 3. It is also leading the clinical development of AV-299, which includes conducting multiple Phase I clinical trials and preparing for the conduct of multiple Phase II clinical trials. The company?s product candidate in preclinical development is AV-203, a potent ErbB3 antibody that has demonstrated efficacy in vivo. It has strategic partnerships with OSI Pharmaceuticals, Inc., Merck, and Biogen Idec, Inc. AVEO Pharmaceuticals was formerly known as GenPath Pharmaceuticals, Inc. and changed its name to AVEO Pharmaceuticals, Inc. in March 2005. The company was founded in 2001 and is based in Cambridge, Massachusetts.
Advisors' Opinion:- [By Sean Williams]
AVEO Pharmaceuticals (NASDAQ: AVEO ) shareholders would just assume bury their heads in the sand following an FDA panel meeting that delivered a 13-to-1 vote against recommending metastatic renal cell carcinoma drug Tivozanib for approval. If you recall, Tivozanib delivered statistically better progression-free survival results in a late-stage head-to-head against Onyx Pharmaceuticals'�and Bayer's Nexavar, but its median overall survival slightly lagged Nexavar. For AVEO to justify the benefits of Tivozanib, another trial seems all but inevitable. AVEO shares fell a whopping 67% on the week.
Best Information Technology Companies To Invest In 2015: NAPCO Security Technologies Inc.(NSSC)
Napco Security Technologies, Inc., together with its subsidiaries, manufactures and sells security products for intrusion, fire, video, wireless, access control, and door locking systems. The company offers intrusion and fire alarms, building access control systems, and electronic locking devices for commercial, residential, institutional, industrial, and governmental applications. Its access control systems comprise identification readers, control panel, personal computer-based computer, and electronically activated door-locking devices; alarm systems include automatic communicators, control panels, combination control panels/digital communicators and digital keypad systems, door security devices, fire alarm control panels, and area detectors; and video surveillance systems consists of video cameras, control panel, and video monitor or personal computer. The company also markets peripheral and related equipment manufactured by other companies. It sells and markets its pro ducts to independent distributors, dealers, and installers of security equipment worldwide. The company was formerly known as NAPCO Security Systems, Inc. and changed its name to Napco Security Technologies, Inc. in January 2009. Napco Security Technologies, Inc. was founded in 1969 and is headquartered in Amityville, New York.
Advisors' Opinion:- [By Jim Powell]
A more speculative idea, and a companion stock to ADT, I recommend Napco Security Technologies (NSSC). The company supplies security systems, primarily to commercial, institutional, industrial, and government customers.
Hot Dividend Companies To Watch In Right Now: Glacier Media Inc (GLMFF.PK)
Glacier Media Inc. (Glacier) is an information communications company focused on the provision of information and related services through print and digital media. Glacier has two segments: the newspaper and trade information markets and the business and professional information markets. The operations in the newspaper and trade information group include the Western Producer Publications and Farm Business Communications agricultural information group, Business In Vancouver Media Group, the JuneWarren-Nickle�� Energy Group, the Business Information Group, and the Glacier Newspaper Group. Its operations in the business and professional information group include Specialty Technical Publishers, CD-Pharma, Eco Log and a joint venture interest in Fundata. In November 2011, the Company acquired a 50% interest in InfoMine Inc. In November 2011, the Company acquired Canada�� Outdoor Shows Limited. In December 2011, it acquired Postmedia Network Inc.'s community newspapers in British Columbia. Advisors' Opinion:- [By Mike Arnold]
Shares of Glacier Media (GLMFF.PK)(GVC.TO) ("Glacier" or "the company") are cold product in this market of stocks, trading at decade lows after a summer sell-off. Famed value investor Walter Schloss preferred buying stocks not at 52-week lows, but at multi-year lows. If Mr. Schloss were here with us today, I suspect he'd be taking a look at Glacier shares.
Best Information Technology Companies To Invest In 2015: STERIS Corporation(STE)
STERIS Corporation and its subsidiaries develop, manufacture, and sell infection prevention, contamination control, microbial reduction, and surgical support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide. It provides steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers; liquid chemical sterilant processing systems; washer/disinfector systems; general and specialty surgical tables; surgical and examination lights; equipment management systems; operating room storage cabinets; warming cabinets; scrub sinks; and other products and accessories. The company also offers connectivity solutions, such as operating room integration, workflow, patient tracking, and instrument management that allow transfer of information and images; cleaning chemistries and sterility assurance products; cleansing products, including hard surface disinfectants, and skin care and hand hygiene solutions; high-pu rity water equipment; vaporized hydrogen peroxide generators. In addition, it sells contract materials processing services using gamma irradiation and ethylene oxide technologies, as well as offers microbial reduction services based on customer specifications. Further, the company provides maintenance programs and repair services, sterilization and surgical management consulting services, information management and decision support services, and other support services, such as construction and facility planning, engineering support, device testing, customer education, hand hygiene process excellence, asset management/planning, and the sale of replacement parts. STERIS Corporation sells its products to end users, dealers, and distributors through direct field sales and service representatives. The company was formerly known as Innovative Medical Technologies and changed its name to STERIS Corporation in 1987. STERIS Corporation was founded in 1985 and is headquartered in Ment or, Ohio.
Advisors' Opinion:- [By Sean Williams]
What: Shares of Steris (NYSE: STE ) �-- a manufacturer of infection prevention, contamination control, and surgical support products for the health-care industry -- jumped as much as 10% after reporting better-than-expected fourth-quarter results.
Best Information Technology Companies To Invest In 2015: Puma Biotechnology Inc (PBYI)
Puma Biotechnology, Inc., incorporated in April 2007, is a development-stage biopharmaceutical company that acquires and develops products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. As of December 31, 2011, the Company licensed three drug candidates: PB272 (neratinib (oral)), which the Company is developing for the treatment of advanced breasts cancer patients and gastric cancer patients; PB272 (neratinib (intravenous)), which the Company is developing for the treatment of advanced cancer patients, and PB357.
PB272 (neratinib (oral))-Breast Cancer
Neratinib is a potent irreversible tyrosine kinase inhibitor, or TKI, that blocks signal transduction through the epidermal growth factor receptors (EGFRs), HER1, HER2 and HER4. The Company's initial focus is on the development of neratinib as an oral treatment of patients with HER2 positive metastatic breast cancer.
PB272 (neratinib (intravenous))
The Company develops neratinib as an intravenously administered agent. In pre-clinical studies the intravenous version of neratinib resulted in higher exposure levels of neratinib in pre-clinical models.
PB357
PB357 is an orally administered agent that is an irreversible TKI that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. PB357 is structurally similar to PB272. Pfizer completed single dose Phase I trials of PB357. The Company is evaluating PB357.
The Company competes with Genentech, GlaxoSmithKline, Roche, Boehringer Ingelheim, Takeda, Array Biopharma and Ambit Biosciences.
Advisors' Opinion:- [By Anna Prior]
Puma Biotechnology Inc.(PBYI) reported positive top-line data from the Phase II clinical trial of the biopharmaceutical company’s investigational drug PB272 for the neoadjuvant treatment of breast cancer.
- [By John Udovich]
Recent news surrounding small cap biotech stocks like�Xencor Inc (NASDAQ: XNCR), Prosensa Holding NV (NASDAQ: RNA),�Puma Biotechnology Inc (NYSE: PBYI),�Geron Corporation (NASDAQ: GERN)
and TNI BioTech Inc (OTCQB: TNIB) show that while the sector and appetite for biotech�IPOs may have cooled, lottery tickets can still be found or occur in the sector. Just consider the following recent news or trends: - [By Lee Jackson]
Puma Biotechnology Inc. (NYSE: PBYI) is a stock that UBS views as having multiple catalysts. The analysts are positive on the potential for their cancer drug neratinib to demonstrate positive data in neoadjuvant breast, as well as specific genetic mutations for other cancers. Success in either area may lead to strong upside for the stock. The UBS price target is $61, while consensus is at $62.50.
Best Information Technology Companies To Invest In 2015: ALCO Stores Inc (ALCS)
Alco Stores, Inc., incorporated on June 2, 1915, is engaged in the business of retailing general merchandise throughout the central portion of the United States of America through a range of department store outlets. The Company�� ALCO stores offer a range of merchandise consisting of approximately 35,000 items, including automotive, commodities, crafts, domestics, electronics, furniture, hardware, health and beauty aids, housewares, jewelry, ladies�� men�� and children�� apparel and shoes, pre-recorded music and video, sporting goods, seasonal items, stationery and toys.
As of February 3, 2013, the Company operated 217 stores in 23 states located in mostly smaller communities in the central United States. The stores average approximately 21,000 square feet of selling space, with an additional 5,000 square feet utilized for merchandise processing, temporary storage and administration.
Advisors' Opinion:- [By Monica Gerson]
ALCO Stores (NASDAQ: ALCS) is projected to post its Q2 earnings.
Digital Cinema Destinations (NASDAQ: DCIN) is estimated to post a Q4 loss at $0.11 per share on revenue of $11.17 million.
Best Information Technology Companies To Invest In 2015: Descartes Systems Group Inc (DSGX)
The Descartes Systems Group Inc. (Descartes) is a global provider of federated network and global logistics technology solutions that help its customers make and receive shipments and manage related resources. The Company�� network-based solutions, which primarily consist of services and software, connect people to their trading partners and enable business document exchange (bookings, bills of lading and status messages); regulatory compliance and customs filing; route and resource planning, execution, monitoring and reporting; inventory and asset visibility; rate and transportation management, and warehouse operations. Its pricing model provides its customers solutions either on a perpetual license, subscription or transactional basis. In December 2013, the Company acquired Compudata and Impatex Freight Software Limited.
The Company�� focus is on serving transportation providers (air, ocean and truck modes), logistics service providers (including third-party logistics providers, freight forwarders and customs brokers) and distribution-intensive companies. To help deliver the resources in motion management solutions (RiMMS) solutions to customers, Descartes developed the Logistics Technology Platform. Descartes��Logistics Technology Platform is synthesis of network, applications and community. The Logistics Technology Platform fuses Descartes��Global Logistics Network (GLN), logistics networks covering multiple transportation modes, with an array of modular, interoperable Web and wireless logistics management applications.
The applications available over the Logistics Technology Platform that work in conjunction with the GLN, help transportation companies and logistics service providers (LSPs) control their shipment management process, comply with regulatory requirements, expedite cross-border shipments and connect and communicate with their trading partners. Applications are also available on the Logistics Technology Platform to help manufacturer, retailer, distribu! tor and mobile service provider (MRDM) enterprises. Its applications are designed to support global trade and compliance systems (GT&C), which encompasses the preparation and filing of the necessary electronic documentation relating to a shipment, such as cross-border customs documentation, freight waybills or manifests; supply chain execution (SCE), which entails the processes related to managing shipments from their point of origin to their point of destination, as well as the documents related to those shipments (booking data, orders, contracts and rates, shipment status, proof of delivery, invoices and payments), and mobile resource management applications (MRM), which involves tracking, information gathering, measuring, reporting, compliance filing, delegating and optimizing the use of mobile assets and people that are involved in the movement of goods.
The Logistics Technology Platform supports a community of over 35,000 trading partners sending over one billion messages annually in over 160 countries. Designed specifically for logistics processes and their users, the Logistics Technology Platform enables organizations to centrally manage information, deliver messages and transform data.Customers use its modular, software-as-a-service solutions to route, schedule, track and measure delivery resources; plan, allocate and execute shipments; rate, audit and pay transportation invoices; file customs and security documents for imports and exports.
Advisors' Opinion:- [By Rich Smith]
Waterloo, Ontario-based Descartes Systems Group (NASDAQ: DSGX ) has acquired KSD Software Norway AS, a company described as a "leading Scandinavia-based provider of electronic customs filing solutions for the European Union ('EU')."
Best Information Technology Companies To Invest In 2015: Banco Macro SA (BMA)
Banco Macro S.A. (the Bank), incorporated on November 21, 1966, is a bank in Argentina. The Bank provides standard banking products and services to a nationwide customer base. The Bank has two categories of customers: retail customers, which include individuals and very small companies, and corporate customers, which include small, medium and large companies and major corporations. In addition, it provides services to four provincial governments. The Bank offers a range of standard products, which are available to both its retail and corporate customers. Retail customers are individuals, entrepreneurs and very small companies (companies with less than Pesos one million in sales per year). It provides services to them throughout Argentina, in particular outside of the City of Buenos Aires, which has higher concentrations of low- and middle-income individuals who are traditionally underserved by large private banks. The Bank serves its retail customers through its nationwide branch network. Approximately 94% of the Bank�� branches are located outside of the City of Buenos Aires.
The Bank offers its retail customers traditional banking products and services, such as savings and checking accounts, time deposits, credit and debit cards, consumer finance loans (including personal loans), mortgage loans, car loans, overdrafts, credit-related services, home and car insurance coverage, tax collection, utility payments, automated teller machines (ATMs) and money transfers. The Bank offers personal loans, document discounts, (housing) mortgages, overdrafts, pledged loans and credit card loans to its retail customers.
The Bank provides its corporate customers with traditional banking products and services, such as deposits, lending (including overdraft facilities), check cashing advances and factoring, guaranteed loans and credit lines for financing foreign trade and cash management services. It also provides them trust, payroll and financial agency services, corporate credit cards a! nd other specialty products. The corporate business is focused on the classification by sizes and sectors. The Bank has four categories for its corporate customers: small companies, which register up to Pesos 52 million in sales per year; medium companies, which register more than Pesos 52 million and less than Pesos 150 million in sales per year; major companies, which register more than Pesos 150 million in sales per year, and agro companies, which operate in agriculture or in the commerce of its products (approximately 97% of its corporate customers are small businesses).
The Bank�� lending activities to the corporate sector (defined here as firms with loans outstanding in excess of Pesos 20,000) totaled Pesos 4,985 million. Most of its lending activity consists of working capital loans to small and medium-sized businesses. The Bank offers short-term and medium- to long-term corporate lending products. Short-term products include credit lines for up to 180 days and consist mainly of overdraft facilities, corporate credit and debit cards and factoring, as well as foreign trade related financing, such as pre-export, post-shipment and import financing. Medium-to long-term products include credit lines and specific lending facilities of more than 180 days.
The Bank offers transaction services to its corporate customers, such as cash management, customer collections, payments to suppliers, payroll administration, foreign exchange transactions, foreign trade services, corporate credit cards and information services, such as its Datanet and Interpymes services. The Bank�� payments to suppliers��services enable its customers to meet their payment obligations to their suppliers on a timely basis through a system. This service also provides payment liquidations, tax payment receipts, invoices and any other documents required by the payer.
The Bank�� collection services include cash or check deposits at its 408 branches, automatic and direct debits from checking ! or saving! s accounts and the transportation of funds collected from corporate customers to its branches for deposit. The Bank provides its corporate clients with access to the Datanet service, which is an electronic banking network linking member banks in Argentina. These services permit its clients to obtain reliable online information on a real-time basis from their bank accounts in Datanet, as well as perform certain transactions. The Bank also provides tax collection and financial agency services to four provinces.
The Bank competes with Santander Rio, Banco de Galicia y Buenos Aires S.A., BBVA Banco Frances S.A., HSBC Argentina S.A. and Banco Patagonia S.A.
Advisors' Opinion:- [By Federico Zaldua]
Despite growing expenses, in local currency terms, the bank's net income improved 16% year-over-year (yoy) while Non-Performing-Loans (NPL) have been kept below 4%. Hence, through Galicia, you can invest in an operationally healthy bank that shall behave in line with government bonds. Trading at 3 times P/E and 75% book value I think Galicia is good bet within the space.
High Exposure to Public Debt
Banco Macro (BMA) has been one of the highest growing banks during the last two decades. One interesting thing about Banco Macro is that the bank owns approximately $400 million of government related securities when the bank's total market capitalization is now just above $1 billion. On the other hand, Banco Macro is growing earnings aggressively at a 39% year over year rate in local currency terms with a very low (and stable) 1.6% NPL rate. Banco Macro is slightly more expensive than Galicia trading at 80% its book value and 3.2 times P/E. - [By Roberto Pedone]
Marco Bank (BMA) offers a range of traditional banking products and services to corporates, SME's and individuals in Argentina. This stock closed up 5.6% at $20.93 in Monday's trading session.
Monday's Volume: 404,000
Three-Month Average Volume: 78,386
Volume % Change: 504%From a technical perspective, BMA jumped sharply higher here right above some near-term support at $19 with strong upside volume. This stock has been uptrending strong for the last two months and change, with shares moving higher from its low of $13.63 to its recent high of $21.73. During that move, shares of BMA have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of BMA within range of triggering a big breakout trade. That trade will hit if BMA manages to take out its 52-week high at $21.73 with high volume.
Traders should now look for long-biased trades in BMA as long as it's trending above some key near-term support levels at $19 to $18.29 and then once it sustains a move or close above its 52-week high at $21.73 with volume that's near or above 78,386 shares. If that breakout hits soon, then BMA will set up to re-test or possibly take out its next major overhead resistance levels at $25 to $27.
No comments:
Post a Comment